454 Attributes Decline in Q2 Revenues to Delays from Customers Awaiting GS FLX+ Upgrade

"Customers delayed purchases of reagents on the GS FLX system as they waited for their upgrade to GS FLX+," said 454 President and CEO Chris McLeod.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.